Literature DB >> 21243922

Cost-effectiveness analysis of unsafe abortion and alternative first-trimester pregnancy termination strategies in Nigeria and Ghana.

Delphine Hu1, Daniel Grossman, Carol Levin, Kelly Blanchard, Richard Adanu, Sue J Goldie.   

Abstract

To explore the policy implications of increasing access to safe abortion in Nigeria and Ghana, we developed a computer-based decision analytic model which simulates induced abortion and its potential complications in a cohort of women, and comparatively assessed the cost-effectiveness of unsafe abortion and three first-trimester abortion modalities: hospital-based dilatation and curettage, hospital- and clinic-based manual vacuum aspiration (MVA), and medical abortion using misoprostol (MA). Assuming all modalities are equally available, clinic-based MVA is the most cost-effective option in Nigeria. If clinic-based MVA is not available, MA is the next best strategy. Conversely, in Ghana, MA is the most cost-effective strategy, followed by clinic-based MVA if MA is not available. From a real world policy perspective, increasing access to safe abortion in favor over unsafe abortion is the single most important factor in saving lives and societal costs, and is more influential than the actual choice of safe abortion modality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21243922

Source DB:  PubMed          Journal:  Afr J Reprod Health        ISSN: 1118-4841


  12 in total

Review 1.  Abortion care in Ghana: a critical review of the literature.

Authors:  Sarah D Rominski; Jody R Lori
Journal:  Afr J Reprod Health       Date:  2014-09

2.  The macroeconomics of abortion: A scoping review and analysis of the costs and outcomes.

Authors:  Yana van der Meulen Rodgers; Ernestina Coast; Samantha R Lattof; Cheri Poss; Brittany Moore
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

Review 3.  Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters.

Authors:  Jeremy D Goldhaber-Fiebert; Margaret L Brandeau
Journal:  Med Decis Making       Date:  2015-04-29       Impact factor: 2.749

4.  The impact of Ghana's R3M programme on the provision of safe abortions and postabortion care.

Authors:  Aparna Sundaram; Fatima Juarez; Clement Ahiadeke; Akinrinola Bankole; Nakeisha Blades
Journal:  Health Policy Plan       Date:  2014-09-25       Impact factor: 3.344

Review 5.  Bibliometric trends of health economic evaluation in Sub-Saharan Africa.

Authors:  Karla Hernandez-Villafuerte; Ryan Li; Karen J Hofman
Journal:  Global Health       Date:  2016-08-24       Impact factor: 4.185

6.  The costs and cost effectiveness of providing first-trimester, medical and surgical safe abortion services in KwaZulu-Natal Province, South Africa.

Authors:  Naomi Lince-Deroche; Tamara Fetters; Edina Sinanovic; Jaymala Devjee; Jack Moodley; Kelly Blanchard
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

7.  Medical Abortion Provided by Nurse-Midwives or Physicians in a High Resource Setting: A Cost-Effectiveness Analysis.

Authors:  Susanne Sjöström; Helena Kopp Kallner; Emilia Simeonova; Andreas Madestam; Kristina Gemzell-Danielsson
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

8.  Estimating the costs for the treatment of abortion complications in two public referral hospitals: a cross-sectional study in Ouagadougou, Burkina Faso.

Authors:  Patrick G C Ilboudo; Giulia Greco; Johanne Sundby; Gaute Torsvik
Journal:  BMC Health Serv Res       Date:  2016-10-07       Impact factor: 2.655

9.  The cost of post-abortion care in developing countries: a comparative analysis of four studies.

Authors:  Michael Vlassoff; Susheela Singh; Tsuyoshi Onda
Journal:  Health Policy Plan       Date:  2016-04-04       Impact factor: 3.344

Review 10.  The mesoeconomics of abortion: A scoping review and analysis of the economic effects of abortion on health systems.

Authors:  Samantha R Lattof; Ernestina Coast; Yana van der Meulen Rodgers; Brittany Moore; Cheri Poss
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.